Suppression of Retinal Neovascularisation by Tetrahedral Framework Nucleic Acids‐Resveratrol Via Dual Anti‐Angiogenesis and Anti‐Inflammation
Cell Proliferation · 2026
DOI: 10.1111/cpr.70227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2026. Verfasst von Yili Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Resveratrol, Retinal Neovascularization, Angiogenesis Inhibitors, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Retinal neovascular diseases, such as retinopathy of prematurity and diabetic retinopathy, threaten vision by disrupting retinal structure and function through pathological neovascularisation and chronic inflammation. Existing anti‐VEGF therapies primarily target angiogenesis, offering limited control over inflammation and requiring repeated administration. Here, we developed a resveratrol (RSV)‐loaded tetrahedral framework nucleic acid nanostructure (tFNAs‐RSV) to achieve concurrent anti‐angiogenic and anti‐inflammatory effects. tFNAs provided a biocompatible, stable and penetration‐efficient carrier that enhanced RSV ocular delivery and bioactivity. In hypoxia‐induced retinal neovascularisation models, tFNAs‐RSV markedly reduced neovascular lesion area, vascular leakage and retinal inflammatory cell infiltration. Mechanistically, tFNAs‐RSV suppressed HIF‐1 signalling and inhibited the p38 MAPK pathway and NF‐κB p65 pathway. Collectively, these results validate tFNAs‐RSV as a promising nanoplatform for treating retinal neovascular diseases, with an emphasis on inhibiting neovascularisation and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Sichuan Eye Medical Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Sichuan Eye Medical Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
- Department of Ophthalmology, General Hospital of Central Theater Command, Wuhan, China.
ORCID-Profile: Xiaoyan Ding
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jin, Y., Cai, T., Huang, J., Chen, L., Lin, Y., Liu, J., Wang, Y., & Ding, X. (2026). Suppression of Retinal Neovascularisation by Tetrahedral Framework Nucleic Acids‐Resveratrol Via Dual Anti‐Angiogenesis and Anti‐Inflammation. Cell Proliferation. https://doi.org/10.1111/cpr.70227
Vancouver
Jin Y, Cai T, Huang J, Chen L, Lin Y, Liu J, et al. Suppression of Retinal Neovascularisation by Tetrahedral Framework Nucleic Acids‐Resveratrol Via Dual Anti‐Angiogenesis and Anti‐Inflammation. Cell Proliferation. 2026. doi:10.1111/cpr.70227
BibTeX
@article{Jin2026,
author = {Jin, Yili and Cai, Tao and Huang, Junyang and Chen, Li and Lin, Yi and Liu, Jingying and Wang, You and Ding, Xiaoyan},
title = {Suppression of Retinal Neovascularisation by Tetrahedral Framework Nucleic Acids‐Resveratrol Via Dual Anti‐Angiogenesis and Anti‐Inflammation},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70227}
}
EUVIMED